Docetaxel induced durable response in advanced extramammary Paget's disease: A case report

Journal of Dermatology

Volumn 29, Issue 1, 2002, Pages 33-37

  Oguchi, Shinji ^a   Kaneko, Miwako ^a   Uhara, Hisashi ^a   Saida, Toshiaki ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Docetaxel; Durable response; Extramammary Paget's disease

Indexed keywords

CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; MITOMYCIN C; VINCRISTINE;

ADULT; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG TOLERABILITY; EDEMA; ERYTHEMA; HUMAN; HUMAN TISSUE; JAPAN; LYMPH NODE METASTASIS; MALE; NEUTROPENIA; PAGET SKIN DISEASE; SCROTUM DISORDER; SKIN BIOPSY;

EID: 0036160422     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2002.tb00162.x     Document Type: Article

References (20)

1. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy
2. Low dose FP (5-FU + Low dose CDDP) therapy for advanced extramammary Paget's disease
3. Criteria for the evaluation direct effects of solid cancer chemotherapy
4. Metastatic extramammary Paget's disease; Dramatic response to combined modality treatment
5. Metastatic vulvar Paget's disease responding to combination chemotherapy
6. Recent advances in the medical chemistry of taxoids with novel β-amino acid side chains
7. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Current status and future directions
8. Late phase II clinical study of RP56976 (Docetaxel) in patients with advanced/recurrent head and neck cancer
9. Late phase II clinical study of RP56976 (Docetaxel) in patients with non-small cell lung cancer
10. A late phase II clinical study of RP56976 (Docetaxel) in patients with advanced or recurrent gastric cancer: A cooperative study group trial (GROUP B)
11. A late phase II clinical study of RP56976 (Docetaxel) in patients with advanced or recurrent breast cancer
12. Weekly Docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma
13. Low-dose weekly administration of docetaxel for metastatic breast cancer
14. Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck
15. Taxanes, their indication and regimen
16. Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline
17. Docetaxel therapy against anthracycline resistant breast cancer
18. Phase II trial of paclitaxel in patients with soft-tissue sarcoma
19. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
20. Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy